Optimal therapy for U.S. hepatitis C patients
News-Medical.Net - He serves as a consultant, investigator and speaker for Schering-Plough. WIN-R Study WIN-R (Weight-Based Dosing of PEG-INTRON and REBETOL) is a community-based access trial involving more than 5,000 patients at 225 centers across the U.S. The uniquely

This entry was posted on Sunday, December 30th, 2007 at 9:48 pm and is filed under General. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.